FutureChem Co.,Ltd (KOSDAQ:220100)

-1.77% (1Y)

Market Cap	416.53B
Revenue (ttm)	18.93B
Net Income (ttm)	-9.99B
Shares Out	22.10M
EPS (ttm)	-452.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,024,421
Average Volume	308,957
Open	20,850
Previous Close	17,620
Day's Range	18,500 - 21,600
52-Week Range	14,900 - 31,250
Beta	1.35
RSI	68.91
Earnings Date	Aug 14, 2025

About FutureChem Co.,Ltd

FutureChem Co.,Ltd engages in the research and development, production, and sale of chemicals, pharmaceuticals, and medical devices in South Korea and internationally. The company offers radioactive pharmaceuticals, including [18F]FDG for the treatment of general cancer diagnosis, PDvue for Parkinson's disease, Alzavue for Alzheimer's disease, and FLT for the lung cancer diagnosis. Its products in pipeline include [18F]FC303, [177Lu]FC705, and 225Ac for the treatment of prostate cancer; F-FMT for brain tumor diagnosis; FC-505 for the treatment ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 68
• Stock Exchange: KOSDAQ
• Ticker Symbol: 220100

Financial Performance

In 2024, FutureChem Co.,Ltd's revenue was 17.29 billion, an increase of 23.81% compared to the previous year's 13.97 billion. Losses were -9.42 billion, 40.4% more than in 2023.